Kuros Biosciences AG
OTC:CSBTF

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
OTC:CSBTF
Watchlist
Price: 38.34 USD Market Closed
Market Cap: 1.4B USD

Wall Street
Price Targets

CSBTF Price Targets Summary
Kuros Biosciences AG

Wall Street analysts forecast CSBTF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSBTF is 49.67 USD with a low forecast of 46.56 USD and a high forecast of 53.86 USD.

Lowest
Price Target
46.56 USD
21% Upside
Average
Price Target
49.67 USD
30% Upside
Highest
Price Target
53.86 USD
40% Upside
Kuros Biosciences AG Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
3% Upside
ALXO
ALX Oncology Holdings Inc
111% Upside
ADMA
ADMA Biologics Inc
34% Upside
BNTX
BioNTech SE
51% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
50% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
37% Upside
MRUS
Merus NV
3% Upside
7774
Japan Tissue Engineering Co Ltd
166% Upside

Revenue
Forecast

Revenue Estimate
Kuros Biosciences AG

For the last 13 years the compound annual growth rate for Kuros Biosciences AG's revenue is 37%. The projected CAGR for the next 4 years is 42%.

37%
Past Growth
42%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Kuros Biosciences AG

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 4 years is 371%.

N/A
Past Growth
371%
Estimated Growth
Estimates Accuracy
33%
Average Beat

Net Income
Forecast

Net Income Estimate
Kuros Biosciences AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSBTF's stock price target?
Price Target
49.67 USD

According to Wall Street analysts, the average 1-year price target for CSBTF is 49.67 USD with a low forecast of 46.56 USD and a high forecast of 53.86 USD.

What is Kuros Biosciences AG's Revenue forecast?
Projected CAGR
42%

For the last 13 years the compound annual growth rate for Kuros Biosciences AG's revenue is 37%. The projected CAGR for the next 4 years is 42%.

What is Kuros Biosciences AG's Operating Income forecast?
Projected CAGR
371%

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 4 years is 371%.

Back to Top